Back to Treatments

Treatment

Intranasal Corticosteroids (INCS)

1
Conditions
6
Trials
300K
Participants
78%
Average Safety

Condition Evidence

Allergic Rhinitis

6 trials · 300K participants

88% effectiveness · 78% safety
Intranasal Corticosteroids (INCS) | DFDA